Template and operational guidance for the ethics review and oversight of COVID-19-related research, 15 April 2020
MetadataShow full item record
Other Language Versions
As part of the response to the COVID-19 pandemic, health research has proliferated. Clinical trials and other studies with human participants are being conducted to find efficacious treatments and vaccines for COVID-19. In this context, research ethics committees (RECs) must be prepared and organized to conduct a thorough ethics review of research, and have rapid and flexible procedures in place to do so efficiently, considering the tight timelines and needs posed by this health emergency. This document aims at providing guidance for RECs to develop standard operating procedures (SOPs) for the rapid review of human subjects research related to COVID-19. It supplements the prior Guidance and strategies to streamline the ethics review and oversight of COVID-19-related research.
This notice should be preserved along with the article's original URL.Attribution-NonCommercial-ShareAlike 3.0 IGO
Showing items related by title, author, creator and subject.
Guidance and strategies to streamline ethics review and oversight of COVID-19-related research, 7 April 2020 Pan American Health Organization; Health Systems and Services (HSS) (Washington, D.C., PAHO, 2020-04-07)Faced with the COVID-19 pandemic, we have the moral duty to conduct research that generates evidence to maintain, promote and improve health care delivery and decision-making, and to define policies for managing and ...
Schonhaut, Luisa; Costa-Roldan, Italo; Oppenheimer, Ilan; Pizarro, Vicente; Han, Dareen; Díaz, Franco (2022-04-13)[ABSTRACT]. Objective. To describe the editorial processing time of published COVID-19 research articles and compare this with a similar topic, human influenza, and analyze the number of publications, withdrawals, ...
Pan American Health Organization; Health Systems and Services (HSS) (Washington, D.C., PAHO, 2020-06-05)This document provides national regulatory authorities (NRAs) with guidance for the regulation of clinical trials (CTs) in order to promote the investigation and use of safe and efficacious medicines and other health ...